Terms: = Ovarian cancer AND TBL1XR1, C21, 79718, TBLR1, IRA1, FLJ12894, DC42 AND Treatment
4 results:
1. Single-cell RNA-sequencing analysis reveals divergent transcriptome events between platinum-sensitive and platinum-resistant high-grade serous ovarian carcinoma.
Wang Z; Yang L; Su X; Wu X; Su R
J Gene Med; 2023 Oct; 25(10):e3504. PubMed ID: 36994597
[TBL] [Abstract] [Full Text] [Related]
2. Progesterone protects ovarian cancer cells from cisplatin-induced inhibitory effects through progesterone receptor membrane component 1/2 as well as AKT signaling.
Zhu X; Han Y; Fang Z; Wu W; Ji M; Teng F; Zhu W; Yang X; Jia X; Zhang C
Oncol Rep; 2013 Nov; 30(5):2488-94. PubMed ID: 23970345
[TBL] [Abstract] [Full Text] [Related]
3. The mechanism for protein kinase C inhibition of androgen production and 17alpha-hydroxylase expression in a theca cell tumor model.
Beshay VE; Havelock JC; Sirianni R; Ye P; Suzuki T; Rainey WE; Carr BR
J Clin Endocrinol Metab; 2007 Dec; 92(12):4802-9. PubMed ID: 17895316
[TBL] [Abstract] [Full Text] [Related]
4. Immunohistochemical and biochemical analysis of a human Sertoli-Leydig cell tumor: autonomous steroid production characteristic of ovarian theca cells.
Sawetawan C; Rainey WE; Word RA; Carr BR
J Soc Gynecol Investig; 1995; 2(1):30-7. PubMed ID: 9420846
[TBL] [Abstract] [Full Text] [Related]
